RESEARCH PARTICIPATION OPPORTUNITIES
Dr. Jacqueline Harris, MD, Kennedy Krieger Institute/Johns Hopkins Medical Institution, specializes in patients with epigenetic disorders with neurologic and/or cognitive manifestations in Kabuki Syndrome. Dr. Harris is currently conducting several research studies and is seeking participants. Please see the individual study details below.
LATEST NEWS & INFORMATION
Oryzon announces $1 million grant from Kabuki syndrome philanthropists to support a precision medicine Phase I/II trial with vafidemstat
HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseases
Multicentric study to assess the efficacy of vafidemstat in Kabuki Syndrome patients
Expected to start in early 2022
In collaboration with the Kennedy-Krieger Institute